These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 19524260
1. Growth factor manipulation of intestinal angiogenesis: a possible new paradigm in the management of inflammatory bowel disease. Thatch KA, Mendelson KG, Haber MM, Schwartz MZ. J Surg Res; 2009 Oct; 156(2):245-9. PubMed ID: 19524260 [Abstract] [Full Text] [Related]
2. Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2. Alavi K, Schwartz MZ, Palazzo JP, Prasad R. J Pediatr Surg; 2000 Jun; 35(6):847-51. PubMed ID: 10873024 [Abstract] [Full Text] [Related]
3. Hepatocyte growth factor and omega-3-enriched feeds have a synergistic effect on mucosal mass in an animal model of inflammatory bowel disease. Katz MS, Thatch KA, Schwartz MZ. J Pediatr Surg; 2012 Jan; 47(1):194-8. PubMed ID: 22244416 [Abstract] [Full Text] [Related]
4. Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease. Arthur LG, Schwartz MZ, Kuenzler KA, Birbe R. J Pediatr Surg; 2004 Feb; 39(2):139-43; discussion 139-43. PubMed ID: 14966727 [Abstract] [Full Text] [Related]
5. Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin. Bertrand V, Quéré S, Guimbaud R, Sogni P, Chauvelot-Moachon L, Tulliez M, Lamarque D, Charreire J, Giroud JP, Couturier D, Chaussade S, Breban M. Eur Cytokine Netw; 1998 Jun; 9(2):161-70. PubMed ID: 9681392 [Abstract] [Full Text] [Related]
6. Gene alterations and intestinal mucosal changes following growth factor and omega-3 exposure in a rat model of inflammatory bowel disease. Katz MS, Thatch KA, Schwartz MZ. J Pediatr Surg; 2013 Feb; 48(2):345-52. PubMed ID: 23414863 [Abstract] [Full Text] [Related]
8. Dose variation of hepatocyte growth factor and its effects on an animal model of TPN-induced liver injury. Katz MS, Thatch KA, Schwartz MZ. J Surg Res; 2010 Oct; 163(2):294-8. PubMed ID: 20691983 [Abstract] [Full Text] [Related]
9. The intestinal microvasculature as a therapeutic target in inflammatory bowel disease. Hatoum OA, Heidemann J, Binion DG. Ann N Y Acad Sci; 2006 Aug; 1072():78-97. PubMed ID: 17057192 [Abstract] [Full Text] [Related]
10. Hepatocyte growth factor ameliorates inflammatory bowel disease in a rat model. Arthur LG, Kuenzler KA, Schwartz MZ. J Gastrointest Surg; 2003 Dec; 7(8):1062-8; discsussion 1068. PubMed ID: 14675716 [Abstract] [Full Text] [Related]
12. [Studies on the influence of Candida fungal colonization on the healing process of inflammatory lesions in the colon in rat animal model]. Zwolińska-Wcisło M, Brzozowski T, Budak A, Sliwowski Z, Drozdowicz D, Kwiecień S, Trojanowska D, Rudnicka-Sosin L, Mach T, Konturek SJ, Pawlik WW, Targosz A. Przegl Lek; 2007 Jan; 64(3):124-9. PubMed ID: 17941462 [Abstract] [Full Text] [Related]
13. Attenuation of mouse acute colitis by naked hepatocyte growth factor gene transfer into the liver. Hanawa T, Suzuki K, Kawauchi Y, Takamura M, Yoneyama H, Han GD, Kawachi H, Shimizu F, Asakura H, Miyazaki J, Maruyama H, Aoyagi Y. J Gene Med; 2006 May; 8(5):623-35. PubMed ID: 16479533 [Abstract] [Full Text] [Related]
14. [Effect of hepatocyte growth factor on intestinal permeability and bacterial translocation after small bowel transplantation in rat]. Li K, Li N, Li J. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 May; 21(5):532-5. PubMed ID: 17578297 [Abstract] [Full Text] [Related]
15. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy. Guo YH, He JG, Wu JL, Yang L, Zhang DS, Tan XY, Qi RD. Cytotherapy; 2008 May; 10(8):857-67. PubMed ID: 18956268 [Abstract] [Full Text] [Related]
16. Reduction of colonic inflammation in HLA-B27 transgenic rats by feeding Marie Ménard apples, rich in polyphenols. Castagnini C, Luceri C, Toti S, Bigagli E, Caderni G, Femia AP, Giovannelli L, Lodovici M, Pitozzi V, Salvadori M, Messerini L, Martin R, Zoetendal EG, Gaj S, Eijssen L, Evelo CT, Renard CM, Baron A, Dolara P. Br J Nutr; 2009 Dec; 102(11):1620-8. PubMed ID: 19622193 [Abstract] [Full Text] [Related]
17. Influence of luminal hepatocyte growth factor on small intestine mucosa in vivo. Kato Y, Yu D, Lukish JR, Schwartz MZ. J Surg Res; 1997 Jul 15; 71(1):49-53. PubMed ID: 9271277 [Abstract] [Full Text] [Related]
18. Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease. Punekar S, Zak S, Kalter VG, Dobransky L, Punekar I, Lawler JW, Gutierrez LS. Pathobiology; 2008 Jul 15; 75(1):9-21. PubMed ID: 18334835 [Abstract] [Full Text] [Related]
19. Pharmacogenomic analysis of rhIL-11 treatment in the HLA-B27 rat model of inflammatory bowel disease. Peterson RL, Wang L, Albert L, Marchese E, Erickson J, Wong A, Mounts WM, Hayes L, Bouchard P, Keith J, Dorner AJ. Pharmacogenomics J; 2002 Jul 15; 2(6):383-99. PubMed ID: 12629504 [Abstract] [Full Text] [Related]